Abstract

Policy makers and insurers promote the use of generic drugs because they can deliver large savings without sacrificing quality. But these efforts meet resistance from the public, who perceive generic drugs as inferior substitutes for brand name counterparts. Building on literature showing that negative emotions reduce risk-taking, the authors hypothesize that receiving bad medical news (i.e., negative information about one’s health) prompts patients to favor brand name over generic drugs as means to safeguard their health. The evidence exploits low-density lipoprotein cholesterol test results, where a discontinuity from clinical guidelines enables the authors to estimate the causal effect of bad medical news.

Citation

Hermosilla, M., & Ching, A. T. (2024). Does Bad Medical News Reduce Preferences for Generic Drugs? Journal of Marketing, 88(1), 160-178. https://doi.org/10.1177/00222429231158360